Skip to main content
Tami John, MD, Pediatric Hematology & Oncology, Palo Alto, CA

TamiDeniseJohnMD

Pediatric Hematology & Oncology • Palo Alto, CA

Clinical Associate Professor, Pediatric Stem Cell Transplant and Regenerative Medicine

Join to view full profile

Dr. John is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. John's full profile

Already have an account?

  • Office

    725 Welch Rd
    Palo Alto, CA 94304
    Phone+1 650-497-8000

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Stem Cell Transplant, 2016 - 2017
  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 2013 - 2016
  • University of California Davis Health
    University of California Davis HealthResidency, Pediatrics, 2010 - 2013
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2010

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2025
  • TX State Medical License
    TX State Medical License 2016 - 2023
  • OR State Medical License
    OR State Medical License 2011 - 2011
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Early Career Clinician Award Baylor, 2021

Publications & Presentations

PubMed

Journal Articles

  • Dismantling cost and infrastructure barriers to equitable access to gene therapies for sickle cell disease  
    Akshay Sharma, Tami D John, The Lancet Hematology, 7/1/2024

Abstracts/Posters

  • Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative Disorders
    Tami D John, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era
    Tami D John, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without C...
    Tami John, ASH annual meeting, 12/1/2019
  • Join now to see all

Lectures

  • Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Black Teen with Sickle Cell Disease First Gene Therapy Patient at Texas Medical Center
    Black Teen with Sickle Cell Disease First Gene Therapy Patient at Texas Medical CenterMarch 17th, 2022
  • Katy Teen Is the First Texas Medical Center Patient to Receive Gene Therapy for Sickle Cell Disease
    Katy Teen Is the First Texas Medical Center Patient to Receive Gene Therapy for Sickle Cell DiseaseMarch 15th, 2022
  • Gene Therapy for Neurologic Disease
    Gene Therapy for Neurologic DiseaseJune 21st, 2024

Dr. Tami John, Dr. Tami John, MD, Dr. T John, Dr. Tami Denise John